Market Cap : 3.05 B | Enterprise Value : 3.5 B | PE Ratio : 15.15 | PB Ratio : 2.91 |
---|
NAS:PDCO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:PDCO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Patterson's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2022 was $58 Mil. Patterson's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2022 was $532 Mil. Patterson's Total Stockholders Equity for the quarter that ended in Apr. 2022 was $1,042 Mil. Patterson's debt to equity for the quarter that ended in Apr. 2022 was 0.57.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Patterson's Debt-to-Equity or its related term are showing as below:
During the past 13 years, the highest Debt-to-Equity Ratio of Patterson was 9.82. The lowest was 0.03. And the median was 0.50.
PDCO's Debt-to-Equity is ranked worse thanThe historical data trend for Patterson's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Patterson's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Patterson's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Patterson's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
Patterson's Debt to Equity Ratio for the fiscal year that ended in Apr. 2022 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (58.348 | + | 531.886) | / | 1041.676 | |
= | 0.57 |
Patterson's Debt to Equity Ratio for the quarter that ended in Apr. 2022 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (58.348 | + | 531.886) | / | 1041.676 | |
= | 0.57 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Thank you for viewing the detailed overview of Patterson's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Mckoy Philip | director | 120 BROADWAY SUITE 200 SANTA MONICA CA 90401 |
Rogan Timothy E | officer: President - Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Shirley Eric R | officer: President-Patterson Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Zurbay Donald | officer: Chief Financial Officer | C/O ST. JUDE MEDICAL, INC. ONE ST JUDE MEDICAL DRIVE ST. PAUL MN 55117 |
Malecha Francis Joseph | director | 9900 WEST 109TH STREET, SUITE 100 OVERLAND PARK KS 66210 |
Frohning Andrea L. | officer: Chief Human Resources Officer | 13515 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Frenzel Robert | director | 414 NICOLLET MALL MINNEAPOLIS MN 55401 |
Goedken Dennis W | officer: Interim CFO | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Walchirk Mark S | director, officer: President & CEO | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Pohlman Kevin M | officer: President - Animal Health | 822 7TH STREET, SUITE 740 GREELEY CO 80631 |
Blanco Alex N | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Misiak David G | officer: President, Patterson Dental | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55120 |
Baker Kelly A | officer: CHRO | 1031 MENDOTA HEIGHTS ST. PAUL MN 55120 |
Korsh Les B | officer: VP, General Counsel | 1031 MENDOTA HEIGHTS ROAD ST. PAUL MN 55110 |
Adent John Edward | officer: CEO - Subsidiary | 822 7TH STREET, SUITE 740 GREELEY CO 80631 |
Other Sources
By Zacks 2022-03-17
By Zacks 2022-02-09
By Zacks 2022-01-12
By Zacks 2022-03-01
By Zacks 2021-12-27
By Zacks 2022-01-14
By Zacks 2022-03-28
By Zacks 2022-03-22
By Zacks 2022-01-11
By Zacks 2022-02-24
By Zacks 2022-03-02
By Zacks 2022-01-05
By Zacks 2022-01-14